Manayunk resident Rebeca Cruz-Esteves had her first dose of the Pfizer COVID vaccine on March 17. As a young mother in a pandemic, she was hypervigilant about her health: She called her gynecologist ...
About 100 people who have received the one-dose Johnson & Johnson COVID-19 vaccine have developed a rare neurological disorder called Guillain-Barré Syndrome about two weeks after getting their shot, ...
HOUSTON -- A Houston woman spent 22 days in the hospital suffering from a rare disorder known as Guillain-Barré that she said her doctor determined was brought on as a result of a very rare reaction ...
LABEL TO BE PLACED ON THE JOHNSON & JOHNSON SHOT. A NEW WARNING FROM THE FDA ABOUT THE JOHNSON AND JOHNSON COVID VACCINE. FLAGGING IT FOR POTENTLLYIA SLIGHT DEVELOPING THE RISK OF A RARE NEUROLOGICAL ...
WASHINGTON (AP) — Johnson & Johnson’s COVID-19 vaccine may pose a “small possible risk” of a rare but potentially dangerous neurological reaction, U.S. health officials said Monday. The Centers for ...
Both Pfizer and GSK’s upcoming respiratory syncytial virus (RSV) vaccines had instances of Guillain-Barré syndrome in clinical trials. And yet the FDA is only recommending that one of them conduct a ...
About 100 people who have received the one-dose Johnson & Johnson COVID-19 vaccine have developed a rare neurological disorder called Guillain-Barré Syndrome about two weeks after getting their shot, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results